logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Blonanserin CAS NO:132810-10-7

Blonanserin CAS NO:132810-10-7

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 132810-10-7

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
132810-10-7
Appearance ::
White To Off-white Powder
Molecular Formula::
C23H30FN3
Molecular Weight::
367.51
EINECS NO::
685-975-6
MDL NO::
MFCD00893838
CAS NO::
132810-10-7
Appearance ::
White To Off-white Powder
Molecular Formula::
C23H30FN3
Molecular Weight::
367.51
EINECS NO::
685-975-6
MDL NO::
MFCD00893838
Blonanserin CAS NO:132810-10-7

Product Description:

Product Name: Blonanserin CAS NO:132810-10-7

 

 

 

 

 

 

Synonyms:

2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine;

 

 

 

 

 

 

Chemical & Physical Properties:

Appearance :white to off-white powder

Assay :≥99.0%

Density:1.1g/cm3

Boiling Point: 540.8℃ at 760 mmHg

Flash Point:280.9℃

 

 

 

 

 

 

 

Blonanserin (Lonasen) is a relatively new atypical antipsychotic (approved by PMDA in January 2008) commercialized by Dainippon Sumitomo Pharma in Japan and Korea for the treatment of schizophrenia. Relative to many other antipsychotics, blonanserin has an improved tolerability profile, lacking side effects such as extrapyramidal symptoms, excessive sedation, or hypotension. As with many second-generation (atypical) antipsychotics it is significantly more efficacious in the treatment of the negative symptoms of schizophrenia compared to first-generation (typical) antipsychotics such as haloperidol.

 

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.